The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•13 February 2026•

1 min read

Prospera Cuts Regeneron Stake Amid Strong Q3 Earnings Beat and Dividend Hike

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Prospera Financial Services Inc. reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 38.0% during the third quarter, now holding 8,766 shares valued at $4.93 million. This portfolio adjustment comes despite Regeneron reporting a significant beat on its third-quarter earnings expectations. The company posted an EPS of $11.44 and revenues of $3.88 billion, surpassing analyst estimates. Furthermore, Regeneron increased its quarterly dividend, signaling robust financial performance. Analysts maintain a "Moderate Buy" consensus rating for the stock, with a target price of $793.81. These developments present mixed signals for investors, balancing institutional portfolio adjustments against strong underlying company fundamentals.